ID: ALA5275341

Max Phase: Preclinical

Molecular Formula: C11H10BrN5OS2

Molecular Weight: 372.27

Associated Items:

Representations

Canonical SMILES:  Cc1nnsc1C(=O)NNC(=S)Nc1ccccc1Br

Standard InChI:  InChI=1S/C11H10BrN5OS2/c1-6-9(20-17-14-6)10(18)15-16-11(19)13-8-5-3-2-4-7(8)12/h2-5H,1H3,(H,15,18)(H2,13,16,19)

Standard InChI Key:  RLMRMEPXHNPFGJ-UHFFFAOYSA-N

Associated Targets(non-human)

Toxoplasma gondii 4585 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.27Molecular Weight (Monoisotopic): 370.9510AlogP: 2.24#Rotatable Bonds: 2
Polar Surface Area: 78.94Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.84CX Basic pKa: CX LogP: 2.65CX LogD: 1.79
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.55Np Likeness Score: -2.96

References

1. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X..  (2021)  Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations.,  64  (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569]

Source